The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.00
Bid: 1,766.00
Ask: 1,766.50
Change: 32.50 (1.87%)
Spread: 0.50 (0.028%)
Open: 1,736.00
High: 1,767.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-U.S. election risks in focus

Wed, 30th Sep 2020 11:50

* European shares in the red

* Chaos marks first Trump-Biden debate

* China's factory activity accelerates
Welcome to the home for real-time coverage of European equity markets brought to you by Reuters
stocks reporters. You can share your thoughts with Joice Alves (joice.alves@thomsonreuters.com)
and Julien Ponthus (julien.ponthus@thomsonreuters.com) in London and Stefano Rebaudo
(stefano.rebaudo@thomsonreuters.com) and Danilo Masoni (danilo.masoni@thomsonreuters.com) in
Milan.

U.S. ELECTION RISKS IN FOCUS (1048 GMT)

Markets turned their attention towards U.S. politics on Wednesday after the first U.S.
presidential debate overnight saw President Trump laying the groundwork to dispute the election
while in Deutsche Bank Jim Reid's words: "there was very little substance in the debate and
almost no new information proffered" from both candidates.

"Those looking for any real clarity from last night's presidential debate have been left
empty handed. The debate essentially showed two septuagenarians squabbling amongst themselves
and failing to really commit to anything substantial," says John Woolfitt, director of trading
at Atlantic Markets.

Biden's chances however were rising on betting markets after the debate, with Betfair
Exchange showing the Democratic candidate's probability of winning at 60%, up from 56% before
the debate. Trump has a 40% chance.

Sonja Laud, CIO at LGIM speaking at the firm's media webinar, says her team is closely
watching "the risk of higher taxes that actually all democrats candidates have one way or the
other in their plans."

"It's very clear that market hasn't really paid a lot of attention to political events for
quite some time, and obviously are now trying to catch up".

More readings:

GLOBAL MARKETS-Stocks pull back as acrimonious U.S. debate stokes caution

Insults and interruptions mar first Trump-Biden debate

European stocks sapped by virus, U.S. election worries

(Joice Alves)

*****

SEPTEMBER FLOWS: TINA "STILL IN PLAY" (1004 GMT)

Markets have become more erratic as of late but Barclays finds that the so-called TINA
(there is no alternative) effect that's been supporting equities is "still in play".

It finds that not much de-risking has taken place in September with mutual funds reducing
cash exposure to buy more equities, albeit more selectively.

Global equity funds had 15 billion inflows mtd, while money market funds in contrast saw 133
billion in outflows and have now unwound 30% of their ytd inflows, it notes.

(Danilo Masoni)

*****

A REAL ESTATE BUBBLE IN THE EURO ZONE? (0926 GMT)

Real estate did not suffer much from the coronavirus crisis as lower-for-longer rates and
stimulus plans supported demand, but some cities might have stepped into bubble-risk territory.

According to UBS, the major cities at risk of a bubble are in the euro zone.

Three reasons are behind the recent surge in prices, according to UBS.

Home prices are a backward-looking indicator of the economy as they react with a delay to
economic downturns. Then the number of transactions declined, while most potential home buyers
did not suffer direct income losses in first half of 2020.

"Credit facilities for companies and short-time work schemes mitigated the fallout from the
crisis, supporting employees’ housing affordability," it says.

“It’s clear that the current acceleration is not sustainable. Rents have been falling
already in most cities, indicating that a correction phase will likely emerge when subsidies
fade out and pressure on household incomes increases,” it adds.

In many cities buying from investors willing to rent is going to be subdued as
“price-to-rent ratios have reached a record-high and rental growth is uncertain.”

(Stefano Rebaudo)

*****

OPENING SNAPSHOT: M&A DRIVES TOP MOVERS, SHELL UP, AIRBUS DOWN (0729 GMT)

European shares opened almost flat after earlier indications from futures for a loss.

M&A newsflow is the driver behind top movers.

TP ICAP is down 8% after the world's biggest inter-dealer broker said it's in
advanced talks to buy electronic trading network Liquidnet Holdings for $600-700 million, while
Covestro is down 4.9% on news it will purchase Dutch peer DSM's Resins and
Functional Materials business for about 1.6 billion euros.

In the opposite direction, French utility Suez is up 6.6% after peer Veolia
sweetens its offer for a 29.9% stake in the rival.

Royal Dutch Shell is off to a volatile start. After hitting March lows the stock is
now up more than 1% as it looks investors are giving thumbs up to its plans to cut its workforce
by up to 9,000 10% as part of a major shift to low-carbon energy.

Airbus is down 1.4% after Reuters reports the WTO has authorized the EU to impose
tariffs on U.S. goods worth $4 billion, raising the prospect of more trade frictions ahead

(Danilo Masoni)

*****

SHELL OVERHAUL, MORE M&A, AND CHIPMAKERS ON OUR RADAR (0652 GMT)

The chaotic Trump-Biden debate did nothing to soothe worries over a contested election
outcome and it barely moved the needle in betting markets, which give a narrow Biden victory.

It may be little surprise then that U.S. futures are currently taking a hit, down more than
1%, and the open in Europe isn't going to be much different.

The positive China data may have a negligible impact on sentiment, while a Reuters report
that the WTO has authorized the EU to impose tariffs on U.S. goods worth $4 billion has raised
the prospect of more trade frictions ahead.

In corporate news, Royal Dutch Shell announced on Wednesday plans to cut up to
9,000 jobs, or over 10% of its workforce, as part of a major overhaul to shift the oil and gas
giant to low-carbon energy. Its shares are seen up 1%.

M&A continues with German plastics maker Covestro buying Dutch peer DSM's
Resins and Functional Materials business for about 1.6 billion euros. The news is set
to weigh on Covestro shares, which fell 2.9% in early trade.

In the UK, William Hill has agreed to be acquired by Caesars Entertainment.

In earnings, a downbeat sales forecast from chipmaker Micron could have a negative
readacross for sector peers here in Europe. Infineon shares fell more than 1% in
premarket trade.

In more positive news, Swiss adhesives and construction materials maker Sika looked
upbeat. It confirmed its target for annual sales growth of 6-8% until 2023 and said it expects
more favourable second-half market conditions even as the COVID-19 pandemic continues.

British online fashion retailer Boohoo reported a 51% increase in first half profit
and raised its full year guidance, while shares in IT solutions supplier S&T rose
1.9% in premarket trade after saying it may exceed full year 2020 guidance.

The world's largest catering firm Compass however expects annual organic revenue to
fall by 19% and said it would impair about 100 million pounds worth of assets as it reviews its
contracts to deal with the blow from the COVID-19 pandemic.

Eyes also on exchange stocks such as Deutsche Boerse, Euronext and LSE
after news that Trump's antitrust chief will scrutinize Wall Street data feed pricing
heavily hit shares in US exchange stocks.

On the COVID-19 treatment front there is some good news. A single dose of Johnson &
Johnson's experimental vaccine produced a strong immune response against the novel coronavirus
in an early-to-mid stage clinical trial, while GSK said it was optimistic
the industry will be able to make an immunisation against COVID-19 widely available next year.

(Danilo Masoni)

*****

MORNING CALL: GOING DOWN POST TRUMP-BIDEN DEBATE (0534 GMT)

Shares in Europe look set for a lower start this morning as a chaotic Trump-Biden debate,
which did little to soothe worries about a contested election, outweighs positive data from
China, where factory activity expanded at a faster pace in September.

Euro STOXX futures were last trading down 0.6%, adding to losses seen yesterday
when markets pulled back after a big rally at the start of the week.

Over in Asia, shares rose slightly with MSCI's broadest index of Asia-Pacific shares outside
Japan up 0.2%, while U.S. futures were last showing declines of 0.7%.

(Danilo Masoni)

*****

More News
Today 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.